Find uplifting stories about heroes, innovations, and solutions
2826 results for "cannabis regulation"
After four years of legal chaos, Thailand is finally bringing order to its cannabis industry by requiring all 11,000 shops to convert into medical clinics. The three-year transition marks Asia's first country to decriminalize cannabis moving toward regulated, medicine-only use.
Ghana is starting to issue licenses for medical cannabis production, making history as the first West African nation to regulate therapeutic cannabis. The move could create new health solutions and economic opportunities across the region.
Morocco is building a thriving medical cannabis industry with strict regulations and scientific research at its core. Over 100 CBD-based products are now available nationwide, offering new hope for patients with chronic pain, epilepsy, and other conditions.
New Jersey just made it easier for legal cannabis businesses to grow, with $5 million in grants still available to help small companies cover compliance costs. Licensed operators can get up to $75,000 to reimburse expenses tied to meeting state regulations.
A decade after Jamaica decriminalized cannabis, Caribbean nations are turning their traditional expertise into a thriving legal industry with global potential. With perfect growing conditions and new US drug policy shifts, the region is positioned to become a major player in medical cannabis exports.
A groundbreaking study of 26,362 adults over 40 found that people who reported using cannabis in their lifetime had larger brain volumes and scored higher on memory tests than non-users. The research challenges old assumptions about cannabis harming the brain, though scientists stress the findings don't prove cause and effect.
The federal government is pushing to reclassify cannabis, a change that could trigger the largest wave of medical research funding in the drug's history. After decades of regulatory roadblocks, scientists may finally get the tools to answer crucial questions about cannabis as medicine.
People who switched to cannabis beverages reduced their weekly alcohol consumption by more than half, according to new research from the University at Buffalo. The familiar social experience of holding a canned drink may make cannabis beverages an easier substitute for heavy drinkers looking to cut back.
A groundbreaking clinical trial proves cannabis can effectively treat acute migraines, offering hope to millions who suffer debilitating attacks. The study found low-dose vaporized cannabis delivered significant pain relief within two hours, with benefits lasting up to 48 hours.
Ten years after Jamaica decriminalized cannabis, the Caribbean is emerging as a global leader in medicinal marijuana cultivation and research. Recent US policy shifts could open new export markets for island growers.
The Netherlands completed its first year of legal cannabis sales with zero criminal infiltration among licensed growers. What started as a decades-old policy headache is showing early signs of a workable solution.
States that legalized recreational cannabis saw daily opioid use drop by up to 11 percentage points among people who inject drugs. The finding suggests safer alternatives can help reduce dependence on dangerous substances.
Scientists at UC Riverside discovered that compounds in cannabis beyond THC may help explain why regular users often have lower body weight and diabetes risk. The finding could lead to new treatments that offer metabolic benefits without intoxication.
Scientists at the University of Arizona discovered that terpenes from cannabis plants significantly reduce chronic pain without causing psychoactive effects. One compound called geraniol showed especially promising results for fibromyalgia and post-surgical pain.
Toxic "forever chemicals" in seabird eggs have plummeted up to 74% over 55 years, proving that environmental regulations actually work. The dramatic decline tracks directly with government action to restrict PFAS production across North America.
Older adults are embracing medical cannabis faster than any age group, finding relief from pain, anxiety, and insomnia. Doctors are now catching up to help guide them safely through a landscape far different from decades past.
A groundbreaking UC San Diego study proves low-dose cannabis effectively treats acute migraines, with two-thirds of patients experiencing pain relief within two hours. The placebo-controlled trial offers hope for millions seeking alternatives to traditional migraine medications.
Scientists discovered that two non-intoxicating cannabis compounds dramatically reduced liver fat and improved metabolic health in new research. The breakthrough offers hope for treating a disease affecting one-third of adults worldwide.
People who switched to cannabis beverages cut their alcohol consumption from 7 drinks per week to just 3, according to a first-of-its-kind study from the University at Buffalo. The research offers fresh hope for anyone looking to reduce drinking without going cold turkey.
%3Amax_bytes(150000)%3Astrip_icc()%2FCannabis-Compounds-Reverse-Fatty-Liver-Disease-FT-DGTL0726-b37d8c4164cd41338ee3e866028de742.jpg)
Two cannabis compounds reversed liver damage in obese mice, offering new hope for millions with the most common chronic liver disease worldwide. Scientists are cautiously optimistic but say human trials are needed next.
Showing 20 of 2826